Obesity medication: Novo Nordisk to sell Wegovy directly to patients at lower price

Novo Nordisk has announced the launch of NovoCare Pharmacy, a new initiative that will offer its weight-loss drug Wegovy directly to patients in the U.S. at a reduced price of $499 per month